Why the study?
What clinical features distinguish true neuroleptic malignant syndrome from NMS-like acute medical illnesses in patients on neuroleptic medication?
Population
34 hospitalized patients with suspected neuroleptic malignant syndrome (NMS)
Design
Cohort
Authors
Loading...
May aid differentiation via targeted signs in neuroleptic-treated patients; leaves open need for prospective validation before changing diagnostic practice.
What clinical features distinguish true neuroleptic malignant syndrome from NMS-like acute medical illnesses in patients on neuroleptic medication?
Distinguishing NMS from other acute medical illnesses requires careful clinical evaluation, as features like fever and CK levels may be similar, but specific signs like rigidity, diaphoresis, and cogwheeling are more common in true NMS.
Sewell et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: